DBV Technologies (DBVT) Common Equity (2015 - 2026)

DBV Technologies (DBVT) posted quarterly Common Equity of $160.4 million for Q2 2026, up 86.08% year-on-year from $86.2 million in Q2 2025, and down 22.85% on a QoQ basis from $207.9 million in Q1 2026.

DBV Technologies (DBVT) Common Equity (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Common Equity for 12 consecutive years, with $160.4 million the latest figure, recorded in Q2 2026.

  • Quarterly Common Equity rose 86.08% year-over-year to $160.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $160.4 million (up 86.08% YoY) and the FY2025 annual result came in at $168.8 million, up 516.06% from the prior year.
  • Common Equity retreated to $160.4 million in Q2 2026 per DBVT's latest filing, from $207.9 million in the prior quarter.
  • Over the last five years, Common Equity for DBVT reached as high as $244.4 million in Q2 2022 and fell as low as $2.9 million in Q1 2025.
  • A 5-year average of $128.4 million and a median of $142.1 million in 2023 frame the typical range for Common Equity.
  • Annual changes were most pronounced in 2025 — Common Equity tumbled 97.4% — and 2026, when it surged 7068.97%.
  • Year by year, Common Equity stood at $194.5 million in 2022, then slipped by 27.91% to $140.2 million in 2023, then slumped by 80.45% to $27.4 million in 2024, then jumped by 516.06% to $168.8 million in 2025, then slipped by 4.98% to $160.4 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $160.4 million, $207.9 million, and $168.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 DBV Technologies 267.50 Mn 92.60 Mn - 160.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 160.40 Mn
Mar 31, 2026 207.90 Mn
Dec 31, 2025 168.80 Mn
Sep 30, 2025 52.85 Mn
Jun 30, 2025 86.20 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 27.40 Mn
Sep 30, 2024 54.03 Mn
Jun 30, 2024 79.10 Mn
Mar 31, 2024 111.65 Mn
Dec 31, 2023 140.19 Mn
Sep 30, 2023 143.99 Mn
Jun 30, 2023 164.24 Mn
Mar 31, 2023 179.09 Mn
Dec 31, 2022 194.45 Mn
Sep 30, 2022 212.05 Mn
Jun 30, 2022 244.42 Mn
Mar 31, 2022 82.06 Mn
Dec 31, 2021 99.27 Mn
Sep 30, 2021 116.89 Mn